|
Market Closed -
Other stock markets
|
After market 01:47:44 pm | |||
| 17.45 EUR | -1.41% |
|
17.46 | +0.03% |
| 04:36pm | German chemicals union pushes for investments at Evonik amid restructuring | RE |
| 01:19pm | Evonik to Streamline Portfolio, Management Under Revised Group Structure | MT |
| Capitalization | 8.25B 8.65B 7.69B 6.81B 12.27B 734B 13.55B 95.03B 35.23B 302B 32.51B 31.78B 1,317B | P/E ratio 2024 * |
16.3x | P/E ratio 2025 * | 12x |
|---|---|---|---|---|---|
| Enterprise value | 11.61B 12.18B 10.82B 9.59B 17.28B 1,033B 19.08B 134B 49.59B 425B 45.76B 44.73B 1,854B | EV / Sales 2024 * |
0.77x | EV / Sales 2025 * | 0.75x |
| Free-Float |
53.47% | Yield 2024 * |
6.61% | Yield 2025 * | 6.71% |
More valuation ratios
* Estimated data
More news
Last Transcript: Evonik Industries AG
More recommendations
More press releases
More news
| 1 day | -1.47% | ||
| 1 week | -2.08% | ||
| Current month | +0.49% | ||
| 1 month | -0.68% | ||
| 3 months | -12.66% | ||
| 6 months | -6.58% | ||
| Current year | -5.68% |
1 week
17.22
18.00
1 month
17.2218.04
Current year
16.6821.27
1 year
16.6821.27
3 years
15.7929.73
5 years
15.1331.00
10 years
15.1337.75
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 2017-05-23 | |
Maike Schuh
DFI | Director of Finance/CFO | 51 | 2023-03-31 |
Tim Lange
IRC | Investor Relations Contact | - | 2011-10-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Rüdiger
BRD | Director/Board Member | 60 | 2013-03-10 |
| Director/Board Member | 58 | 2014-06-30 | |
Martin Albers
BRD | Director/Board Member | 58 | 2015-09-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.99% | 202 M€ | -.--% | ||
| 1.60% | 18 M€ | +7.68% | ||
| 0.87% | 2 M€ | +15.94% | ||
| 0.50% | 79 M€ | -.--% | ||
| 0.49% | 2 M€ | +13.56% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -1.41% | -2.08% | +0.09% | -37.09% | 8.65B | ||
| +0.07% | -0.49% | +25.50% | +7.63% | 70.45B | ||
| -0.49% | +1.85% | +15.91% | -15.83% | 41.97B | ||
| -1.04% | -2.31% | -9.66% | -39.20% | 41.64B | ||
| -1.50% | +0.38% | +17.45% | +19.23% | 27.49B | ||
| -0.72% | -1.50% | -8.12% | -33.83% | 16.49B | ||
| -0.29% | +0.88% | -2.45% | -20.51% | 15.25B | ||
| -2.97% | -4.36% | -28.33% | -59.65% | 12.14B | ||
| -1.74% | +1.64% | +21.60% | +45.85% | 11.64B | ||
| -2.76% | +0.63% | -29.63% | -31.28% | 11.23B | ||
| Average | -1.30% | +1.21% | +0.24% | -16.47% | 25.7B | |
| Weighted average by Cap. | -0.89% | +1.02% | +7.57% | -11.53% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 15.17B 15.91B 14.14B 12.53B 22.57B 1,350B 24.93B 175B 64.79B 555B 59.79B 58.44B 2,422B | 15.21B 15.95B 14.17B 12.56B 22.63B 1,354B 24.99B 175B 64.97B 557B 59.95B 58.6B 2,429B |
| Net income | 518M 543M 483M 428M 770M 46.09B 851M 5.97B 2.21B 18.95B 2.04B 1.99B 82.68B | 694M 728M 647M 573M 1.03B 61.79B 1.14B 8B 2.97B 25.4B 2.74B 2.67B 111B |
| Net Debt | 3.36B 3.53B 3.13B 2.78B 5B 299B 5.53B 38.74B 14.36B 123B 13.25B 12.95B 537B | 3.14B 3.3B 2.93B 2.6B 4.68B 280B 5.17B 36.21B 13.43B 115B 12.39B 12.11B 502B |
More financial data
* Estimated data
Employees
32,040
Sector
Specialty Chemicals
Calendar
2025-03-05
- Q4 2024 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-13 | 17.45 € | -1.41% | 1,156,277 |
| 24-12-12 | 17.70 € | +0.54% | 617,265 |
| 24-12-11 | 17.60 € | -1.89% | 1,282,114 |
| 24-12-10 | 17.94 € | +0.17% | 866,529 |
| 24-12-09 | 17.92 € | +0.53% | 1,243,992 |
Delayed Quote Xetra, December 13, 2024 at 11:35 am EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
17.70EUR
Average target price
21.68EUR
Spread / Average Target
+22.49%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EVK Stock